Validation of the Risk Model: High-Risk Classification and Tumor Pattern of Invasion Predict Outcome for Patients with Low-Stage Oral Cavity Squamous Cell Carcinoma

Head and Neck Pathology

Volumn 7, Issue 3, 2013, Pages 211-223

  Li, Yufeng ^h   Bai, Shuting ^j   Carroll, William ⁱ   Dayan, Dan ^b   Dort, Joseph C ^c   Heller, Keith ^d   Jour, George ^e   Lau, Harold ^c   Penner, Carla ^f   Prystowsky, Michael ^g   Rosenthal, Eben ⁱ   Schlecht, Nicolas F ^g   Smith, Richard V ^g   Urken, Mark ^e   Vered, Marilena ^b   Wang, Beverly ^d   Wenig, Bruce ^e   Negassa, Abdissa ^g   Brandwein Gensler, Margaret ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c TOM BAKER CANCER CENTRE   (Canada)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

^f UNIVERSITY OF MANITOBA   (Canada)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ Kentucky   (United States)

^j University of Alabama at Birmingham   (United States)

more..

Author keywords

Low stage; Oral cavity; Pattern of invasion; Risk Model; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RISK; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK; ROC CURVE; TREATMENT OUTCOME;

EID: 84883747612     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-012-0412-1     Document Type: Article

References (25)

1. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for oral tongue cancer. Laryngoscope. 2002;112: 616-25.
2. Jerjes W, Upile T, Hamdoon Z, et al. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112: 180-7.
3. Huang TY, Hsu LP, Wen YH, et al. Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol. 2010;46: 49-55.
4. Brandwein-Gensler M, Lewis C, Lee B, et al. Oral squamous cell carcinoma: histological risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;20: 167-78.
5. Jakobsson PA, Eneroth CM, Killander D, et al. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol. 1973;12: 1-8.
6. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinoma. Scan J Dent Res. 1987;95: 229-49.
7. Bryne M, Koppang HS, Lilleng R, et al. New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989;18: 432-7.
8. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166: 375-81.
9. Bryne M, Jenssen N, Boysen M. Histologic grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virch Arch. 1995;427: 277-81.
10. Brandwein-Gensler M, Smith RV, Wang B, et al. Validation of the histological Risk Model in a new patient cohort with primary head and neck squamous cell carcinoma. Am J Surg Pathol. 2010;34: 676-88.
11. Vered M, Dayan D, Dobriyan A, et al. Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol. 2010;136: 1039-48.
12. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16: 1141-54.
13. Fine JP, Gray RJ. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc. 1999;94: 456-509.
14. Brennan S, Corry J, Kleid S, et al. Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT-staged T1-2 N0 squamous cell carcinoma of the oral tongue. Head Neck. 2010;32: 191-8.
15. Fukano H, Matsuura H, Hasegawa Y, Nakamura S. Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck. 1997;19: 205-10.
16. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in squamous carcinoma of tongue a prospective randomized trial. Am J Surg. 1989;158: 309-13.
17. Sporano A, Weinstein G, Challian A, et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004;131: 472-6.
18. Bundgaard T, Rossen K, Henriksen SD, et al. Histologic parameters in the evaluation of T1 squamous cell carcinomas of the oral cavity. Head Neck. 2002;24: 656-60.
19. Odell EW, Jani P, Sherriff M, et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer. 1994;74: 789-94.
20. Po WYA, Lam KY, Lam LK, et al. Prognostic factors of clini- cally stage I and II oral tongue carcinoma. A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck. 2002;24: 513-20.
21. Sawair FA, Irwin CR, Gordon DJ, et al. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med. 2003;32: 1-9.
22. Warburton G, Nikitakis NG, Roberson P, et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg. 2007;65: 475-84.
23. Maleki S, Schlecht NF, Keller C, et al. Lymphocytic host response to oral squamous cell carcinoma: an adaptive T-cell response at the tumor interface. Head Neck Pathol. 2011;2: 117-22.
24. Kawakita D, Hosono S, Ito H, et al. Impact of smoking status on clinical outcome in oral cavity cancer patients. Oral Oncol. 2012;48: 186-91.
25. de Matos FR, Lima Ed, Queiroz LM, da Silveira EJ. Analysis of inflammatory infiltrate, perineural invasion, and risk score can indicate concurrent metastasis in squamous cell carcinoma of the tongue. J Oral Maxillofac Surg. 2012;70: 1703-10.